Ligand Pharmaceuticals LGND Professional Service Fees Payable
Professional Service Fees Payable at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AccruedProfessionalFeesCurrent.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's professional service fees payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's professional service fees payable?
- Ligand Pharmaceuticals (LGND) reported professional service fees payable of $2.74M in Q1 2026.
- How has Ligand Pharmaceuticals's professional service fees payable changed year-over-year?
- Ligand Pharmaceuticals's professional service fees payable decreased by 49.5% year-over-year, from $5.43M to $2.74M.
- What is the long-term trend for Ligand Pharmaceuticals's professional service fees payable?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's professional service fees payable has grown at a 15.4% compound annual growth rate (CAGR), from $977K to $2M.